Search results
Cim Investment Management Inc. Trims Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 7 hours agoCim Investment Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing ...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Biogen</ ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 2 hours agoHowever, to Lilly’s advantage, the panel said such risks could be addressed by “appropriate...
Biogen executive plays down looming competition for its Alzheimer's drug
Reuters via AOL· 2 days ago(Reuters) -Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes...
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 5 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities ...
Biogen Inc. Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIIB Investors with Losses to...
Morningstar· 4 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...
Gabelli Funds LLC Has $3.80 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoGabelli Funds LLC trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 4 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.? Bernstein Liebhard LLP announces that ...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 3 days agoThat is likely good news for Biogen and Eisai whose similar Alzheimer’s therapy will benefit from a...
...That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages...
Morningstar· 5 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen